Skip to main content

Table 2 TESTsmART study outcomes

From: Incentivizing appropriate malaria case management in the private sector: a study protocol for two linked cluster randomized controlled trials to evaluate provider- and client-focused interventions in western Kenya and Lagos, Nigeria

Type

Name

Client sample

Client-level outcome

Arm-level summary

Arm-level formula

Primary

ACT consumption by true malaria cases

All clients who purchased an ACT

1 = positive malaria testa and purchases ACT

0 = otherwise

Proportion of ACTs that are sold to malaria test-positivea clients

\( \frac{\#\mathrm{clients}\ \mathrm{who}\ \mathrm{purchased}\ \mathrm{ACT}\ \mathrm{and}\ \mathrm{tested}\ \mathrm{positive}}{\#\mathrm{clients}\ \mathrm{who}\ \mathrm{purchased}\ \mathrm{ACT}} \)

Secondary

Use of malaria rapid diagnostic test

All suspected malaria casesb

1 = tested with mRDT

0 = otherwise

Proportion of suspected malaria cases that receives a malaria test

\( \frac{\#\mathrm{suspected}\ \mathrm{malaria}\ \mathrm{cases}\ \mathrm{tested}\ \mathrm{with}\ \mathrm{mRDT}}{\#\mathrm{suspected}\ \mathrm{malaria}\ \mathrm{cases}} \)

Adherence to mRDT result

All clients who were tested with mRDT

1 = positive malaria test and purchases ACT OR negative malaria test and did not purchase any AM

0 = otherwise

Proportion of malaria tested clients whose treatment adhered to test results

\( {\displaystyle \begin{array}{c}\#\mathrm{clients}\ \mathrm{that}\ \mathrm{tested}\ \mathrm{positive}\ \mathrm{with}\ \mathrm{mRDT}\ \mathrm{and}\ \mathrm{purchase}\mathrm{d}\ \mathrm{ACT}+\\ {}\frac{\#\mathrm{clients}\ \mathrm{that}\ \mathrm{tested}\ \mathrm{negative}\ \mathrm{with}\ \mathrm{mRDT}\ \mathrm{and}\ \mathrm{d}\mathrm{id}\ \mathrm{not}\ \mathrm{purchase}\ \mathrm{AM}}{\#\mathrm{clients}\ \mathrm{tested}\ \mathrm{with}\ \mathrm{mRDT}}\end{array}} \)

Appropriate case mgmt

All suspected malaria casesb

1 = positive malaria test and purchases ACT OR negative malaria test and did not purchase any AM

0 = otherwise

Proportion of suspected malaria cases that are managed appropriately

\( {\displaystyle \begin{array}{c}\#\mathrm{clients}\ \mathrm{that}\ \mathrm{tested}\ \mathrm{positive}\ \mathrm{with}\ \mathrm{mRDT}\ \mathrm{and}\ \mathrm{purchase}\mathrm{d}\ \mathrm{ACT}+\\ {}\frac{\#\mathrm{clients}\ \mathrm{that}\ \mathrm{tested}\ \mathrm{negative}\ \mathrm{with}\ \mathrm{mRDT}\ \mathrm{and}\ \mathrm{d}\mathrm{id}\ \mathrm{not}\ \mathrm{purchase}\ \mathrm{AM}}{\#\mathrm{suspected}\ \mathrm{malaria}\ \mathrm{cases}}\end{array}} \)

ACT use among the untested

All untested clients

1 = purchased ACT

0 = otherwise

Proportion of untested clients taking ACT

\( \frac{\#\mathrm{untested}\ \mathrm{clients}\ \mathrm{who}\ \mathrm{purchased}\ \mathrm{ACT}\ }{\#\mathrm{untested}\ \mathrm{clients}\ } \)

  1. amRDT+ based on RDT conducted at retail outlet or positive by test conducted outside of the retail outlet when documentation is provided
  2. bA “suspected malaria case” is any client who was tested with an mRDT or was untested but purchased any antimalarial (AM)